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ABSTRACT

THE EFFECT OF THIOMAX™ ON IMMUNE FUNCTION IN YOUNG AND
AGED FELINES
Hendey, Lindsay Fitz
University of Dayton
Advisor: Dr. Robert J. Kearns

Aging is associated with several physiological changes. An important
physiological change seen in aging is a shift in the balance between oxidants and
antioxidants, in which increased oxidants, or free radicals, seen with aging lead to
increased cellular damage, also called oxidative stress. Immune function of elderly
individuals seems to be significantly impacted through a decline of immunologic function
as well as dysregulation of inflammatory and specific immune responses. Oxidative
stress and the accumulation of free radicals have been implicated in the decline of
immune function seen in the aged. Antioxidants, both intracellular and exogenous,
counteract free radical damage to cells through the inactivation of free radicals. Through
their free radical inactivation and scavenging capabilities, dietary antioxidants have been
shown to ameliorate several age-related disease states associated with the accumulation
of free radicals and improve immune function in the elderly.
The objective of this study was to determine whether the antioxidant cocktail
Thiomax™ had any effect on immune function, through measurement of mitogeninduced lymphocyte proliferation, lymphocyte subsets, antibody production, and
prostaglandin E2 (PGE2) production in young and old felines. Similarly, the effects of
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Thiomax™ on glutathione status, and oxidative stress, as measured by serum lipid
peroxidation, were measured in these animals. Twenty young (2.68-2.75 years) and aged
(9.12-16.22 years) felines were maintained on a control or Thiomax™ diet throughout the
treatment period. Aged felines exhibited a significant decline in mitogen-induced
lymphocyte proliferation, CD3+ and CD8+ T cell subsets, and levels of the intracellular
glutathione, whereas IgM production was significantly greater compared to young
felines. Conversely, PGE2 and lipid peroxidation levels were significantly lower in aged
compared to young felines. However, Thiomax™ supplementation did not significantly
impact any of the parameters measured in either young or aged felines. Further studies
need to be conducted with optimal doses of Thiomax™ to further test its effect on
immune function in young and aged felines.
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LITERATURE REVIEW

While several theories of aging have been proposed, a great amount of attention
has been focused on the free radical theory of aging, supported by increasing amounts of
evidence in recent years. This theory is based on the age related shift in the balance of
oxidants and antioxidants, both intracellular such as glutathione or dietary such as
vitamin E and carotenoids, in which increased oxidants in the aged individual leads to
increased cellular damage (1,2). This increase in cellular damage, or oxidative stress, is
observed later in life through deterioration of several cellular processes and oxidative
stress has also been implicated in several disease states. Immune function of elderly
individuals seems to be significantly impacted through a decline of immunologic function
as well as dysregulation of inflammatory and specific immune responses (3, 4). Several
aspects of elderly immune function are impacted including cell-mediated and humoral
immunity, as well as the production and secretion of cytokines. This impact on the
elderly immune system seems to be due, but not limited, to oxidative stress on cells of the
immune system by oxidants, or free radicals (5). While much research has been centered
on the cause of the general decline of the elderly immune system and the accumulation of
free radicals in aged individuals, several researchers are focusing on the effects of
antioxidants and the possibility of using these to reverse or restore some of the damaging
effects of oxidative stress.
The production of free radicals occurs as a normal function of aerobic metabolism
occurring in the mitochondria (2). There are several biological sources of free radicals
including the lipooxygenase and cyclooxygenase pathways in the plasma membrane,
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which produce leukotrienes and prostaglandins, respectively, electron transport and
ubiquinone in the mitochondria, as well as the microsomal membranes of the
endoplasmic reticulum (6). Phagocytic cells, such as macrophages and neutrophils, also
produce free radicals in what is called the “respiratory burst”. This respiratory burst in
phagocytes is defined by an increased intake of oxygen, which is converted to toxic
byproducts with potent antimicrobial activity (7, 8). These free radicals include several
molecules such as reactive oxygen and nitrogen intermediates. These molecules include
superoxide anion (O2*), hydroxyl radical (OH*), hydrogen peroxide (H2O2), hypochlorous
acid (H0C1), nitric oxide (NO), and peroxynitrite (ONOO) (7, 8). Free radicals are
deleterious to several cellular processes; one being through lipid peroxidation, or
autoxidation. Lipid peroxidation is accomplished through the production of a free
radical, which reacts with a lipid, thereby oxidizing it (9). This process is described as a
chain reaction since oxidation of the lipid results in the production o f a subsequent radical
(9). The first lipid oxidation event can produce an alkyl radical from the lipid molecule
itself, through removal of hydrogen, and the alkyl radical can react with molecular
oxygen to form lipid peroxy 1radicals (LOO*) (6). Therefore, subsequent radicals
produced by the first oxidation of lipids can propagate the oxidation of other lipids in the
membrane, possibly resulting in detrimental effects to the cell membrane (9). Lipid
peroxidation is detrimental to cells since the autoxidation of the lipids in the cell
membrane disrupts the fluidity and compromises the integrity of the membrane. Cells of
the immune system are particularly susceptible to membrane damage through free radical
attack since their membranes have a high percentage of polyunsaturated fatty acids (10).
Cells such as macrophages and neutrophils can incur increased oxidative damage during
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the respiratory burst, potentially causing harm to them as well as invading
microorganisms (8). Signal transduction can also be affected by lipid peroxidation of the
cell membrane through increased rigidity o f the membrane (11). Additionally, aging is
associated with an increase in membrane rigidity (6). There is also an age associated
increase in membrane damage due to oxidative stress. A study by Hayashi and
Miyazawa (12) demonstrated a significant increase in lipid hydroperoxides, a by-product
of lipid peroxidation and an indicator of oxidative stress, in aged rat hepatocyte plasma
membranes as compared to those in young rats.
Oxidatively damaged proteins also accumulate in the cells of aged individuals,
possibly leading to loss of cellular and biochemical function (11, 13). Alterations in the
proteolytic capabilities of aged cells has also been observed; compromising their ability
to degrade altered and inappropriately folded proteins and contributing to the
accumulation of oxidatively damaged proteins (14). As a consequence of free radical
attack on the cell membrane, normal metabolic production of free radicals, and exposure
to environmental factors, DNA experiences a heavy dose of oxidative lesions. This can
lead to mutations and DNA damage, and although there are several DNA repair
mechanisms in the cell, as a person or animal ages these lesions accumulate faster than
can be repaired (2). Cells which can remain in a quiescent state for years, such as
lymphocytes, are more susceptible to DNA damage by free radicals, and studies suggest
an accumulation of DNA damage in lymphocytes with aging (15). Since mitochondria
are the site of oxidative phosphorylation in eukaryotes and a major source of free
radicals, mitochondrial DNA is subject to a much higher level of oxidative damage than
experienced by nuclear DNA (11). In addition to the DNA damage caused by oxidative
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stress in the mitochondria, organelles also experience significant oxidative damage to
membrane lipids and cellular proteins, all of which seem to contribute to the decline in
mitochondrial function seen in the aged (11) This decline in mitochondrial function,
commensurate with a decline in energy production, resulting from oxidative stress has
been hypothesized to contribute the process of aging (11).
The accumulation of free radicals has been associated with several disease states
including cardiovascular disease, cancer, and viral infections. Cardiovascular disease
(CVD) is a major cause of morbidity among the aging (16). Atherosclerosis is a
component of CVD and is associated with chronic inflammation of the arterial walls as
well as an accumulation of plaque in these arteries (17). Oxidative stress, or an
accumulation of free radicals, has been implicated in the pathogenesis of CVD.
Following injury to arteries, either bacterial, viral, or physical, endothelial cells of the
artery release chemotactic molecules, which recruit monocytes to the area of injury and
initiate an inflammatory response (17). In addition to the recruitment of monocytes,
arterial endothelial cells increase the uptake and modification of lipids from blood;
specifically, there is an increased uptake of low-density lipoproteins (LDLs), which
deliver cholesterol to cells (16). Free radicals produced by activated
monocytes/macrophages and arterial endothelial cells oxidize the LDLs leading to the
formation of plaque in the arterial wall, or atherosclerosis (18).
Cancer is seen with increased frequency in the aged (17). Oxidative stress has
been implicated in the pathogenesis of cancer since free radicals attack DNA leading to
strand breaks and base and nucleotide damage (19). DNA damage caused by free radical
attack can initiate mutagenesis of genes, leading to carcinogenesis and possibly loss of
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tumor suppressor genes (17). Higher levels of free radicals have also been associated
with certain types of cancer. In a study performed by Ray et al. (19), women with breast
cancer had significantly higher levels of hydrogen peroxide (H2O2) and superoxide anion
(O2*') than control women. It could be hypothesized that the increased production of free
radicals in cancer could compound the damage incurred during this disease.
Viral infections such as pneumonia, influenza, and the human immunodeficiency
virus (HTV) pose a major health threat to the elderly and the population as a whole. The
aged-associated decline in immune function increases the susceptibility of elderly
individuals to these infections, which are a chief component of morbidity in the elderly
(20, 21). An increased production of free radicals is associated with viral infections, in
part due to the respiratory burst of phagocytes in response to infection (22, 23). In mice
infected with the influenza virus, increased H2O2 concentration was detected in the lungs
(21). Oxidative stress is also documented in HTV infections. Allard et al. (23) found
increased oxidative stress in HTV infected humans, as measured by increased lipid
peroxidation, compared to non-infected individuals. The production of free radicals has
also been associated with several aspects of a viral infection. Lung damage seen in
influenza infections may be attributable to the effects of free radicals on these tissues
(21). Free radicals may also contribute to successful viral replication. Hydrogen
peroxide (H2O2) has been shown in vitro to enhance HTV replication (22, 23). A cascade
o f events following the expression of influenza hemagglutinin (HA) is suggested to
increase the production of free radicals (24). The increased production of free radicals
and subsequent oxidative stress in viral infections can be particularly detrimental to
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elderly individuals already experiencing elevated oxidative stress, increased susceptibility
to infections, and decreased immune function.
Additionally, the accumulation of free radicals may also contribute to alterations
in immune function. The process of aging is associated with a decline in immune
function leading to increased susceptibility to infections (4). Dysregulation of the
immune and inflammatory responses, also seen in aged individuals, can lead to
autoimmune and chronic inflammatory diseases such as multiple sclerosis and systemic
lupus (4). Free radicals can impact several aspects of the immune system including cellmediated immunity, humoral immunity, as well as secretion of cytokines and
inflammatory mediators.
Cell-mediated immunity is the branch of the immune system dealing primarily
with the elimination of intracellular pathogens and altered self-cells. Helper T cells (Th
cells) and cytotoxic T lymphocytes (CTLs) characterized by the membrane marker CD4+
and CD8+, respectively, are the effector cells generated during a cell-mediated immune
response (25, 26). Th cells secrete various cytokines that activate phagocytic cells for
pathogenic clearance and CTLs mediate killing of altered-self cells, such as tumors and
virally infected cells (26).
Cell-mediated immunity is impacted in several ways in the aged. For example, in
the aged there seems to be an aged related shift in lymphocyte subsets. Aged individuals
have a higher proportion of memory (antigen experienced) T lymphocytes compared to
naive (antigen inexperienced) T lymphocytes (27). Nagel et al. (28) reported a
significant decrease in cytotoxic T lymphocytes (CD8+) in elderly humans as compared
to young subjects, while there was no significant difference in helper T (CD 4) cells.
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Another study found a significant decrease in lymphocytes expressing the membrane
marker CD3+, which represents the total mature T cell population, in the elderly, which
may be reflected in the decrease of CD8+ T lymphocytes (28). There seems to be
conflicting evidence as to whether there is a reduction in the total T cell population in the
elderly, however, results confirm an aged-related shift of increased memory T cells and
decreased naive T cells. This trend may be partially explained by thymic atrophy. The
thymus is the lymphoid organ in which T cell maturation occurs, and even starting early
in life thymic function and size decrease (29). Therefore, less mature naive T
lymphocytes may leave the thymus in older individuals (30), supported by evidence of
decreased naive T cell values in the elderly. This age-related decline in production of
naive T cells may contribute to the loss of immunologic vigor in response to new or
rarely encountered antigens (27).
The proliferative response of lymphocytes to mitogenic and antigenic stimulation
is also depressed in the aged (31, 32). Proliferation of splenic murine lymphocytes
stimulated with concanavalin A (ConA), a known T cell mitogen, was significantly
decreased in aged animals when compared to young animals (31). Additionally, other
studies have shown aged splenic murine T lymphocytes showed a reduced proliferative
response to mitogenic stimulation (27, 33). Isolated peripheral blood mononuclear cells
(PBMCs) from elderly human subjects stimulated with the T cell mitogens Con A and
phytohemagglutinin (PHA) showed decreased 3H-thymidine incorporation (34). Elderly
humans also had a decreased response to and production of the cytokine interleukin 2
(IL-2), which has been shown to control mitogen-induced proliferation in lymphocytes,
when compared with young subjects (35). While elderly human and animal T

7

lymphocytes exhibit decreased proliferative response to non-specific stimulation
(mitogens), these cells also show decreased proliferation in response to stimulation with
specific antigens (32). In a study examining the immune response to the influenza
vaccine, Gardner et al. (36) found elderly human subjects had a significantly reduced
proliferative response to stimulation with a trivalent influenza vaccine compared to
young subjects, both pre- and post-immunization with the same trivalent influenza
vaccine. Delayed-type hypersensitivity (DTH), an in vivo correlate of cell-mediated
immunity, has also been shown to decrease in the aged (37).
Free radicals have been implicated in a decrease in cell-mediated immunity in the
elderly. In an experiment conducted by Pahlavani and Harris, young and aged exposed to
H2O2 and xanthine-xanthine oxidase (X/XO) showed reduced proliferation in response to
Con A stimulation compared to controls (31). The increased susceptibility of
lymphocytes, because of their high membrane lipid content, to free radical attack can lead
to damage of cellular receptors important to proliferation (3). The experimental evidence
demonstrating the diminished cell-mediated immune function in elderly humans and
animals and the damaging role of free radicals elucidates one factor in the decline of
immune function in the elderly.
Humoral immunity is characterized by the interaction of B cells with antigen
resulting in the activation, proliferation, and differentiation into effector plasma cells,
which secrete antibodies (38). The development of an effective humoral immune
response involves the synergism of helper T cells (Th cells, CD4+), cytokines secreted
from these activated Th cells, and the subsequent activation of a population of B cells to
secrete antibodies and produce memory B cells (25). Humoral immunity does not seem
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to be affected as significantly as cell-mediated immunity in the aged, but there are several
age related changes (39). The percentage of memory B cells in the elderly is significantly
lower than those in young individuals (32). Memory B cells are critical to mount a rapid
and effective humoral immune response, and this decline of memory B cells seen in the
aged could be implicated in the increased susceptibility to bacterial and viral infections in
the aged. Additionally, the response to vaccines is depressed in the elderly (36) This
decreased humoral immune response to vaccines is distinguished by a lower antibody
response and an increased lag in activation of the response compared to younger
individuals (39). An antibody response is considered protective if antibody titers are > 40
after vaccination, and there is a distinct decrease in protective and intact antibody
responses to vaccines, specifically to the trivalent influenza vaccine, in the elderly (36).
In the aged immune system, a major component of dysregulation is seen in the
inappropriate secretion of cytokines and inflammatory mediators (40). There also seems
to be a shift in the cytokine profile in aged individuals, leading to dysregulation of Th I
and Th2 lymphocyte subset function (20). Cytokines produced by ThI cells are involved
in cell-mediated immunity and include IL-2 and interferon y (IFN-y), while cytokines
produced by Tr2 cells are involved primarily in B cell activation and include interleukin
4 (IL-4) and interleukin 6 (IL-6) (41). IL-6, tumor necrosis factor a (TNF-a), and IFN-y,
important inflammatory cytokines, have also been reported to increase with age. IL-6 is
involved in T cell activation, B cell differentiation, acute phase responses and TNF-a
mediates inflammation, fever responses, and direct cytotoxicity to altered self cells (24,
42). IFN-y inhibits viral replication, activates macrophages, and is involved in
immunoglobulin class switching (24, 42). IL-6 and TNF-a levels detected in the serum
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of unstimulated control mice were significantly higher in old mice compared to young
mice (43). Moreover, stimulated elderly human T cells (CD3+) expressed significantly
elevated levels of TNF-a and IFN-y than young subjects (44). Macrophages are a major
source of IL-6 and in normal, healthy individuals IL-6 is not detectable in the serum,
however IL-6 is detectable in older individuals (40). A study by Beharka et al. found that
detectable levels of 11^6 were produced by unstimulated aged murine macrophages in
culture (4). Additionally, significantly higher levels of IL-6 were detected in supernatants
of cultured elderly human peripheral blood mononuclear cells (PBMCs) than in young
subjects (45). Elevated levels of EL-6 and TNF-a have been associated with several
disease states including human and canine rheumatoid arthritis (46). However, there does
seem to be some discrepancy as to whether there is a spontaneous, i.e. unstimulated and
therefore dysregulated, increase in these cytokines in the aged compared to young
individuals. Beharka et al. (40) reported no age-related increase in IL-6 production in
human PBMCs, either unstimulated or stimulated with the T cell mitogens Con A and
PHA (40). Others have suggested that the increase in inflammatory cytokines such as IL6 and TNF-a may be due to age-related diseases and health status in the elderly, which
were not monitored as closely in previous studies using aged individuals (24, 40, 45).
Interleukin 2 (11^2) is an important cytokine involved in the clonal expansion of T
cell populations (27). One unequivocal finding in the investigation of the aging immune
system is the decreased production of IL-2 in the aged compared to young subjects.
Several studies have found a significant decrease in IL-2 production in stimulated culture
supernatants obtained from aged mouse and rat splenic lymphocytes (3,27, 31), elderly
human PBMCs (35) and serum (45) compared to young subjects. Because of the
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importance of IL-2 in the proliferation of activated helper T cells, the age-related decline
in IL-2 production is implicated in decreased cell-mediated immunity in aged animals
and humans.
Macrophages have an intimate association with cell-mediated immunity through
their role as antigen presenting cells and secretion of cytokines (TNF-a, IL-1, IL-6) and
inflammatory mediators such as prostaglandins. Prostaglandins are important lipid
inflammatory mediators with diverse biological functions. Prostaglandins are produced
by the degradation of phospholipids and the subsequent oxidation of arachidonic acid in
the membranes of various cell types and metabolized via the cyclooxygenase
pathway(47). Macrophages are the major source of prostaglandin E2 (PGE2), with
activated macrophages producing higher levels of PGE2 than resting macrophages.
While normal levels of PGE2 exert a positive effect on cell-mediated immunity, high
levels exert a suppressive effect (3, 48). Inappropriate secretion, or dysregulation of
secretion, of PGE2 has been implicated in several disease states such as chronic
inflammatory disorders (4), atherosclerosis and cancer (47). Dysregulated secretion of
PGE2 in the murine model has been reported, with significantly higher production seen in
aged compared to young animals (47-49). This increase of PGE2 found in aged subjects
may be due to several factors including the fact that aged individuals experience a heavy
oxidative stress load and increased lipid peroxidation, and in the case of macrophages the
free radicals produced by the respiratory burst may contribute to increased oxidative
stress. Prostaglandin production is initiated by peroxidation of membrane
polyunsaturated fatty acids, such as arachidonic acid, and the increased lipid peroxidation
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in aged individuals due to oxidative stress may lead to dysregulated and increased
production of PGE2 (5).
An important consequence of the elevated secretion of PGE2 in aged individuals
is the immunosuppressive effect on cell-mediated immunity, specifically reduced
proliferative capacity of T cells, demonstrated by co-culture experiments. Beharka et al.
performed co-culture experiments in order to elucidate the age-related changes in T cells
and macrophages and reported that co-cultures of aged murine macrophages and T cells
produced significantly elevated levels o f PGE2 compared to young macrophage and T cell
co-cultures (3). Additionally, when young co-cultures were exposed to similar levels of
PGE2 produced by aged macrophages, reduced lymphocyte proliferation and IL-2
production were observed (3). This and other studies support the suppressive effect on
cell-mediated immunity of elevated levels of PGE2 in the aged.
Antioxidants counteract the effects of free radicals by scavenging and inactivating
these molecules, through enzymatic and non-enzymatic mechanisms. The cell has
several natural, or endogenous, antioxidants including the enzymes superoxide dismutase,
catalase, and glutathione peroxidase, glutathione reductase, and the ubiquitous tripeptide
thiol, glutathione (5). Superoxide dismutase catalyzes the degradation of superoxide
anion (O2*) into hydrogen peroxide (H2O2) and oxygen (O2), while catalase reacts with
H2O2 to form water (H2O) and O2 (5). Gluthatione peroxidases are selenium-dependent
enzymes that reduce hydroperoxides (H2O2) to water at the expense of reduced
glutathione (GSH) (50). Superoxides and hydroperoxides are continuously produced
during aerobic respiration and these enzymes are important in inactivating these
molecules before they can be converted into more potent oxidizing agents, such as
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peroxynitrite (ONOO) and hydroxyl radicals (OH*), which can act as initiators of the
chain reaction in lipid peroxidation (50). Glutathione (GSH), a hydrophilic scavenger,
has potent free radical scavenging capacity in itself, due to its sulfydryl group, as well as
participating in the reaction of glutathione peroxidases (50). GSH is involved in several
cellular functions such as protein and DNA synthesis and is an important source of
reducing power for the cell (10, 51). GSH also has been shown to modulate mitogen
stimulated lymphocyte activation and proliferation (52). GSH depletion negatively
impacts proliferation, whereas GSH enhancement positively influences lymphocyte
proliferation (53, 54). GSH levels have been shown to decrease with age, and this agerelated decrease in GSH might contribute to the decline in cell-mediated immunity in the
aged (10, 51). Hu et al. showed that GSH depletion significantly increased the mitogenstimulated production of PGE2, an indicator of oxidative stress and inflammation, by
human skin fibroblasts and human umbilical vein endothelial cells (55). These results
demonstrate that GSH depletion may cause stimulated cells to produce increased amounts
of inflammatory mediators (55).
While the cell has several natural antioxidants, there are a variety of exogenous
compounds with antioxidant properties available to the cell through diet. Compounds
such as vitamin E (a-tocopherol) and carotenoids, such as P-carotene and lutein, function
as free radical scavengers (9, 10, 37, 56-58). These compounds are located in
lipoproteins and membranes where they act to inactivate peroxyl radicals, thereby
interrupting the propagation step of lipid peroxidation, and blocking the formation of
hydroperoxides (50). Selenium and zinc are essential trace elements, their importance in
an antioxidant system partially stems from the fact that zinc is a cofactor for superoxide
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dismutase and selenium is a cofactor for glutathione peroxidase (5). Several other
compounds have antioxidant properties such as melatonin (59), strawberry extract (58),
a-lipoic acid (60), and the synthetic antioxidant n-propyl gallate (61).
Through their free radical inactivation and scavenging capabilities, dietary
antioxidants have been shown to ameliorate several age-related disease states associated
with the accumulation of free radicals and improve immune function in the elderly.
Antioxidant status declines with age as demonstrated by decreased amounts of plasma
vitamins, carotenoids, and enzymatic antioxidants in the elderly (62), therefore
antioxidant supplementation may increase antioxidant status in the elderly.
Antioxidants such as vitamin E and carotenoids are transported in the blood in
conjunction with lipoproteins, specifically LDLs (56). Vitamin E and carotenoids protect
the protein portion of LDLs from oxidative modification, and the subsequent build-up of
arterial plaque, which may lead to progressive cardiovascular disease (2,18).
Antioxidant supplementation, particularly with vitamin E, has been found to reduce
production of chemokines, which recruit immune cells to the endothelium of vessels and
promote inflammation associated with cardiovascular disease (16). Antioxidants have
also been shown to reduce the risk of cancer, and epidemiological evidence has shown
that increased intake of carotenoid rich foods, such as green leafy vegetables and red and
orange colored fruits, has been associated with a decreased risk of certain types of
cancers (56). This association of antioxidants with reduced cancer risk may be due in
part to the free radical scavenging and inactivation and protection of DNA from oxidative
damage and possible mutagenesis, since carotenoids and vitamin E exert a protective
effect and contribute to genome stability (63, 64). Natural killer (NK) cells are a subset
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of lymphocytes that have cytotoxic effects on tumor cells, through non-specific or
antibody-dependent mechanisms, and are an important cell in immunosurveillance
against cancer (65). It has previously been demonstrated that P-carotene enhanced NK
cell activity in elderly males(65). Enhanced NK cell activity through antioxidant
supplementation may help to reduce the incidence of cancer in the elderly. Antioxidants
also help ameliorate the effects of viral infections, in part by reducing the increased
oxidative stress accompanied with viral infections, and have been shown to enhance
elderly individuals protective response to infection. Hayek et al. demonstrated that
vitamin E supplementation reduced viral lung titer in aged mice to comparable levels of
young mice (66). Antioxidant supplementation with vitamin E and vitamin E plus
glutathione significantly reduced lung viral titers and levels of lipid peroxidation markers,
malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE), in the liver of old mice
compared to control old mice (21). Antioxidant supplementation during a viral infection
has also been shown to increase levels of IFN-y, a critical cytokine expressed during a
viral infection in which production is depressed in the elderly, as well as reduced levels
of TNF-a, an inflammatory cytokine whose secretion has been shown to be dysregulated
in the elderly (20, 24). Antioxidant supplementation may also reduce the severity of HIV
infections by contributing to the reduction of oxidative stress and lipid peroxidation (22,
23).
Antioxidant supplementation also works to reduce or restore several of the agerelated alterations in immune function. Antioxidants enhance and modulate several
parameters of elderly immune function including cell-mediated and non-specific immune
function, as well as secretion of cytokines and inflammatory mediators. Chandra et al.
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found elderly subjects given a daily micronutrient supplementation, including several
antioxidants, had significantly higher percentages of total T cells (CD3+) and Th cells
(CD4+), significantly higher lymphocyte proliferation in response to mitogenic
stimulation by PHA, and significantly increased production of IL-2 and IL-2 receptor
than control subjects (67). Daily micronutrient supplementation in older humans found
that supplementation significantly enhanced the delayed-type hypersensitivity (DTH)
response, a direct in vivo correlate of cell-mediated immunity, compared to control
subjects (68). Vitamin E supplementation in old mice significantly increased splenic T
cell proliferation compared to control old mice, significantly increased IL-2 production
compared to control old mice, and vitamin E supplemented old mice had EL-2 levels
comparable to young mice, both control and vitamin E supplemented (27). In a study
performed by Meydani et at, vitamin E supplementation of elderly human subjects
significantly increased Con A induced lymphocyte proliferation and IL-2 production of
isolated PBMCs, and significantly reduced serum lipid peroxide concentration compared
to baseline values before supplementation (37). The increase in the proportion of
memory T cells and decrease of naive T cells is well documented in the aged. Adolfsson
et al. found that vitamin E supplementation in mice increased IL-2 production in elderly
naive T cells and enhanced the ability of elderly naive T cells to progress through 2 cell
cycle divisions, demonstrating that vitamin E may play a role in increasing the immune
response to newly encountered antigens and decreasing the susceptibility to new
infections in the elderly (27). The carotenoid 3-carotene has been shown to modulate
cell-mediated immune function in animals and humans Enhanced T and B cell
lymphocyte proliferation was seen in rats supplemented with 3-carotene compared to
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controls (69). ^ carotene supplementation of young human males showed an increase,
though not significant, in Th cells (CD4+), but did show a significant increase in the
CD4:CD8 ratio compared to the controls (70). Additionally, supplementation of elderly
humans with P-carotene showed an increase of CD4+ helper T cells compared to
controls(71). However, other studies found little or no effect of P-carotene
supplementation on cell-mediated immunity in women (72, 73) or in elderly individuals
(74), but this may possibly be due to differences in research methodology or experimental
design. Dietary supplementation with glutathione has also been shown to enhance cellmediated immunity. A study conducted by Furukawa et al. in mice confirmed the age
related decrease in glutathione concentration as well as decreased cell-mediated immune
responses (mitogenic lymphocyte proliferation and delayed-type hypersensitivity
response) compared to young mice (75). Glutathione supplementation in this study
increased glutathione concentration and cell-mediated immune responsiveness in the
aged mice (75).
Antioxidants have been shown to modulate cytokine expression in the aged and
ameliorate some of the age-related dysregulation in secretion of selected cytokines and
inflammatory mediators. Vitamin E has been shown to decrease production of IL-6 in
human PBMCs (76) and decrease production of TNF-a in rat whole blood cultures (77).
In a study by Beharka et al., vitamin E and melatonin significantly decreased IL-6
production in murine peritoneal macrophages (4). Glutathione supplementation of
human alveolar macrophages in vitro decreased TNF-a and IL-6 production (78).
Increased PGE2 production in aged individuals has been implicated in several
disease states and contributes to the suppression of T cell function. Antioxidants, in
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particular vitamin E, have been shown to modulate the age-related increase in PGE2
production by macrophages. Vitamin E supplementation significantly reduces PGE2
production in murine macrophages compared to controls (47-49). Vitamin E and
melatonin significantly reduced unstimulated PGE2 production by murine macrophages
compared to controls (4). Macrophage production of PGE2 contributes to the reduced
proliferatitve capacity and production of IL-2 by T cells in old mice, and vitamin E
supplementation enhanced IL-2 production and T cell proliferation and this effect was
mediated by the reduction of PGE2 production by macrophages (3).
Several studies have shown that antioxidant supplementation reduces oxidative
stress in the cell through free radical scavenging, ameliorates several age-related diseases
and conditions, and enhances immune function. However, most of these studies have
been performed in rodents or humans. In recent years, there has been an increased
interest in the effects of proper nutrition and antioxidant supplementation in companion
animals (felines and canines) in order to maintain health with age. This interest is two
fold, in that companion animals can serve as another animal model o f antioxidant
supplementation and the benefits of companion animals to humans as pets and in a
functional capacity such as seeing eye dogs, search and rescue dogs, and animals which
help disabled owners function normally. Evidence also suggests a positive influence of
companion animals to human health (79).
An important aspect in canine and feline health is proper immune function, and
like humans and murines, immune function decreases with age in companion animals
(79). Changes in lymphocyte subsets have been observed in aged companion animals.
Kearns et al. demonstrated that the percentage of total T cells, CD4+ helper T cells, and B
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cells decreased in aged canines, with no apparent change in CD8+ cytotoxic T cells in
these animals (80). Greeley et al. also demonstrated an age related decrease in CD4+ T
cells and B cells in the canine (81). A study by Greeley et al. performed in the canine
found a significantly reduced proliferative response of lymphocytes to mitogens and a
decrease, though not significant, of antibody titers in response to vaccination in old dogs
compared to young (81). Other studies have also confirmed the age-related decrease in
mitogen-induced lymphocyte proliferation as well as other age-related changes in
immune parameters, such as decreased DTH response and antibody production in
response to antigenic challenge and an increase in PGE2 production, in canine and feline
(80, 82, 83).
Several studies have examined the effect of antioxidant supplementation on
immune function in companion animals, both in young and aged canines and felines.
Chew et al. showed that dietary supplementation with P-carotene in young dogs
significantly increased DTH skin response, plasma IgG concentration, and percentages of
CD4 helper T cells compared to unsupplemented dogs (84). Similarly, P-carotene
supplementation in old dogs increased mitogen-induced lymphocyte proliferation, DTH
skin response to PHA (a nonspecific antigen), and percentages of CD4+ helper T cells
compared to control animals (80). However, P-carotene does not seem to modulate
immune function in felines (85). Dietary supplementation with the carotenoid lutein in
cats significantly increased lymphocyte proliferation in response to Con A and pokeweed
mitogen (PWM), increased skin DTH responsiveness to vaccine (a specific antigen),
increased percentages of CD4+helper T cells and B cells, as well as significantly
increasing plasma IgG compared to unsupplemented cats (86). Similarly,
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supplementation with dietary lutein in dogs significantly increased mitogen-induced
lymphocyte proliferation to Con A, PHA, and PWM, skin DTH responsiveness to PHA,
increased percentages of CD4 helper T cells and CD8+ cytotoxic T cells as well as cells
expressing the MHC class II cell surface marker, which are found on antigen presenting
cells, compared to dogs on a control diet (87). This study also found that dietary lutein
significantly increased plasma IgG concentration in response to vaccine compared to
unsupplemented dogs (87). A study by Hayek et al. found that vitamin E
supplementation significantly increased lymphocyte proliferation in old and young cats in
response to the mitogens Con A and PWM, respectively (83). This same study also
found that vitamin E supplementation in cats significantly reduced the production of
PGE2 compared to control cats, and vitamin E also produced a trend towards significance
in reducing PGE2 production in aged cats compared to aged controls (83). However,
vitamin E supplementation did not significantly increase mitogen-induced lymphocyte
proliferation in dogs (82).
The numerous studies just reviewed have shown age-related alterations in
immune function in companion animals and that antioxidant supplementation can
enhance immune function in both young and aged companion animals. Thiomax™,
manufactured by Health Span Sciences, is a proprietary antioxidant cocktail composed of
a-lipoic acid and n-propyl gallate. It has been demonstrated that a-lipoic acid and npropyl gallate have effective antioxidant and free radical scavenging capabilities (60, 61,
88-90). Thiomax™ is a supplement used and tested in humans, however, no studies have
been undertaken to determine the efficacy of Thiomax™ in companion animals.
Therefore, the objective of this study was to test the effects of the antioxidant cocktail
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Thiomax™ on immune function, through measurement of mitogen-induced lymphocyte
proliferation, lymphocyte subsets, antibody production, and PGE2 production, as well as
testing the effects of Thiomax™ on glutathione status, and oxidative stress, as measured
by serum lipid peroxidation, in young and aged felines. This study confirmed the agerelated decrease in selected immune parameters and glutathione concentration, however
no consistent effect of Thiomax™ supplementation was found in young or old cats.
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MATERIALS AND METHODS

Animals and Diet'.
Twenty young (2.68-2.75 years) and aged (9.12-16.22 years) felines were used to
assess the effects of the antioxidant cocktail Thiomax™ on immune function. Animals
were housed and maintained at the lams Research and Development Facility in
Lewisburg, OH with 12-hour light and dark cycles and adequate exercise. Animals were
maintained on a nutritionally complete baseline diet, developed by lams, for 4 weeks
prior to commencement of the study. After that time, felines from the young and aged
groups were randomized and assigned either to the control or Thiomax™ diet (Table 1)
formulated by lams. The animals were maintained on this diet for 60 days. Blood was
collected by veinipuncture into heparinized tubes on days 0, 30, and 60 of the treatment
period. Veterinarians from this facility drew blood from the animals at the desired time
points throughout the study.
Isolation o f Peripheral Blood Mononuclear Cells.
A 10 ml sample of heparinized whole blood was collected from each animal on
days 0, 30, and 60 of the treatment period and transported from the lams facility in
Lewisburg, OH to the University of Dayton.

Five hundred microliters was removed

from each sample and centrifuged at 956 x g at 4°C for 10 minutes. The serum was
drawn off and resulting pellet of blood cells was frozen at -70°C for use in measuring
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Table 1: Composition of Control and Thiomax™ diet fed to young and
aged felines

Diet Composition
Acid Fat Hydrolysis
Ash (dry sample)
Calcium
Moisture
Phosphorus
Protein
Gross Energy
Thiomax™

Diet Type
Thiomax™
Control
19.2%
18.9%
6.7%
6.5%
1.1%
1.1%
7.0%
6.6%
1.0%
0.9%
32.2%
36.6%
5124 Cal/gm
5090.4 Cal/gm
0.00%
0.08%
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intracellular glutathione levels. The remaining whole blood was centrifuged in 50 ml
centrifuge tubes (Fisher) at 827 x g at 22°C for 10 minutes and serum was collected and
stored at -70°C for use in measuring levels of lipid peroxidation. Peripheral blood
mononuclear cells (PBMCs) were obtained by diluting the pelleted whole blood up to 30
ml with IX PBS (Gibco), underlaying with 15 ml of Histopaque (Sigma), and
centrifuging at 670 x g at 22°C for 40 minutes. The resulting layer of PBMCs was drawn
off and placed in a sterile 50 ml centrifuge tube (Fisher). Cells were resuspended in IX
PBS (Gibco) and centrifuged at 206 x g at 22°C for 10 minutes. This step was then
repeated for a total of 2 washes. The resulting pellet of PBMCs was resuspended in 2 ml
of media consisting of RPMI-1640 (Sigma) containing penicillin (100 U/ml) and
streptomycin (100 pg/ml)(Sigma) and gentamicin (50 pg/ml) (Gibco) and cell counts
were performed. Isolated PBMCs were used in lymphocyte proliferation assays and for
the measurement of PGE2 production.
Lymphocyte Proliferation Assay (LPAf.
Isolated peripheral blood mononuclear cells (PBMCs) were then used to measure
proliferation in response to mitogenic stimulation with concanavalin A (ConA),
phytohemagglutinin (PHA) and pokeweed mitogen (PWM). Con A and PHA are T cell
mitogens, whereas PWM is a T and B cell mitogen. Isolated PBMCs were adjusted to a
cell concentration of 2x106 cells/ml in complete media consisting of RPMI-1640 (Sigma)
supplemented with 10% fetal bovine serum (Gibco), penicillin (100 U/ml) and
streptomycin (100 pg/ml)(Sigma) and gentamicin (50 pg/ml) (Gibco). One hundred
microliters of cells were dispensed into individual wells of a 96-well flat-bottom
microtiter plate (Costar). PBMCs were then stimulated in triplicate with 100 pi ConA
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(Sigma), PHA (Sigma), and PWM (Sigma) at final concentrations of 5.0gg/ml, 2.5pg/ml,
and l.Opg/ml. Complete media alone added in triplicate wells served as controls. The
cells were incubated for 72 hours at 37°C in a humidified incubator with 5% CO2.
Eighteen hours prior to the termination of the experiment, each well was pulsed with
1pCi 3H-thymidine (50pCi 3H-thymidine/ml) (ICN Biomedical). Tritiated thymidine
incorporation was measured by liquid scintillation (Beckman LS3801) and the
proliferative response of PBMCs to mitogenic stimulation was expressed as corrected
counts per minute (cCPM). Corrected counts per minute were calculated by subtracting
the counts per minute (cpm) of mitogen-stimulated cultures from the cpms of
unstimulated cultures (media alone).
Prostaglandin E2 (PGE2) Production-.
Isolated PBMCs were adjusted to a cell concentration of 5x105 cells/ml with
complete media, consisting of 5% fetal bovine serum (Gibco) and antibiotics as
previously described. One milliliter of each cell suspension was dispensed into
individual wells of a 24-well cluster plate (Costar). In order to stimulate PGE2
production, 100 pi of Con A (25pg/ml) was added to individual wells for a final
concentration of 2.5pg/well Con A. Cells were incubated for 18-20 hrs at 37°C in a
humidified incubator with 5% CO2. Cells were collected and centrifuged at 4,768 x g at
4°C for 10 minutes. Culture supernatants were collected and stored at -70°C until time of
assay.
PGE2 production was measured using the Correlate-CLIA High Sensitivity PGE2
Chemiluminescence Enzyme Immunoassay Kit (Assay Designs, Inc. cat # 910-001).
Briefly, supernatants were diluted 1:10 in complete media and PGE2 standards were
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prepared according to the protocol provided. All reagents were allowed to warm to room
temperature and all wells were performed in duplicate.
Into predetermined wells of a 96-well microtiter plate coated with goat anti
mouse antibodies, 100 pi of complete RMPI-1640 was pipetted into the non-specific
binding wells (NSB) and Bo (maximum binding) wells. One hundred microliters of
PGE2 standards and samples were pipetted into the appropriate wells. Fifty microliters of
assay buffer was pipetted into the NSB wells. Fifty microliters of blue Conjugate
(alkaline phosphatase conjugated with PGE2) was pipetted into each well, except the
Total Activity (TA) and Blank wells. Fifty microliters of the yellow Antibody
(monoclonal antibody to PGE2) was pipetted into each well, except the Blank, TA, and
NSB wells. The plate was then incubated at room temperature with shaking for 2 hours
at 500 rpm The plate was washed three times with wash solution and firmly tapped dry
after final wash Five microliters of blue Conjugate was pipetted into the TA wells
followed by 200ul of CLIA Substrate (alkaline phosphatase substrate) pipetted into every
well with a 10 second delay between wells. The plate was shaken for 1 hour at room
temperature. The plate was read on a Victor2 1420 luminometer (Wallac, Perkin Elmer
Life Sciences), reading each well for 2 seconds with a 10 second delay between each
well. Data was analyzed with AssayZap software (Biosoft) using a 4- parameter logistic
curve program

Measurement o f Intracellular Glutathione.
Intracellular glutathione, a natural intracellular antioxidant, was measured from
erythrocyte lysates using the Colorimetric Assay for Glutathione (Oxford Biomedical
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Research, #GT 10). In order to obtain erythrocyte cell lysates, erythrocyte pellets,
collected previously from 0.5 ml whole blood, were resuspended in 1 ml of 5%
metaphosphoric acid (MPA)(Sigma) at 4°C. Samples were mixed thoroughly by
vortexing and centrifuged at 3000 x g at 4°C for 10 minutes. The upper clear aqueous
layer was collected for use in the glutathione assay. A standard curve was generated as
per protocol using reduced glutathione (Calbiochem) dissolved in 5% MPA (Sigma) and
diluted appropriately with assay buffer. Samples were diluted by adding 200 pi of
sample to 700 pi of assay buffer (1:5 dilution). Nine hundred microliters of assay buffer
alone served as the blank. To standards, samples, and blank, 50 pi of Reagent 1, the
chromogenic reagent, was added with thorough mixing. Fifty microliters of Reagent 2,
30% NaOH, was added to standards, samples, and blank with thorough mixing. Samples
and standards were incubated in a 25°C water bath for 10 minutes in the dark. Final
absorbance was measured at 400nm on a Genesys 2 spectrophotometer (Spectronic).
Results were then extrapolated from the standard curve using the following equation:
[GSH] = {A / (6400 x 1)} x D
where:
[GSH] is the initial glutathione concentration in the sample, pM
A

is the measured absorbance

£400

is the apparent molar extinction coefficient of product measured at 400 nm
(slope of the corresponding straight line of standard curve)

1

is the optical path length

D

is the dilution factor of sample
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Measurement o f Lipid Peroxidation'.
Lipid peroxidation, which correlates to oxidative stress and cellular damage, was
measured in previously collected serum samples. Lipid peroxidation was quantitated
using the colorimetric assay BIOXYTECH® LPO-560 (OxisResearch, # LPO-560).
Briefly, each sample was performed in duplicate, with one aliquot serving as the blank
and the other aliquot serving as the test sample used to measure lipid peroxidation.
Ninety microliters of each serum sample was incubated with 10 pi of catalase, in order to
eliminate H2O2 interference from the samples and obtain a more accurate lipid peroxide
measurement. Samples were incubated at room temperature for 2 minutes. Ten
microliters of reducing reagent, tris(2-carboxyethyl)phosphine (TECP), was added to
each sample blank in order to reduce the lipid peroxides in the sample to the
corresponding alcohols, and 10 pi of deionized water was added to each test sample.
Samples were mixed by vortexing and incubated at room temperature for 30 minutes.
Nine hundred microliters of working reagent, prepared previously as per protocol, was
added to each sample. Each sample was mixed by vortexing for 30 seconds and
incubated at room temperature for 60 minutes.
Samples were centrifuged at 12,000 x g for 10 minutes and supernatants were
collected. The samples were read at 560 nm on a Genesys 2 spectrophotometer
(Spectronic), with deionized water serving as a blank to zero the instrument. The lipid
peroxides were calculated by subtracting the blank sample, treated with reducing reagent,
from the test samples. This yielded the net absorbance, which was due to lipid peroxide
content. The concentration of lipid hydroperoxides was calculated using the following
equation:
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[LOOH] = (Net A56o/ e) * 6
Where:
[LOOH] = Concentration of lipid peroxides in sample (gM)
Net A560 = Net absorbance at 560 nm
g = 0 .0 4 3 1 m M 'c m ’ 1, apparent molar extinction coefficient o f the hydroperoxide

5 = Dilution factor, 11.2

Measurement o f Total IgG and IgM Antibody Titer.
After day 60 of the treatment period, animals were maintained on their respective
diets and vaccinated with Fel-O-Vax® (Fort Dodge Animal Health-Division of Wyeth,
Madison, NJ) according to protocol. After a two week period, serum samples were
obtained to designate a day 0 time point, after which all animals were boosted with the
same vaccine. Serum samples were then obtained from all animals at day 7, 14, and 21.
Collected serum samples were used to measure total IgG and IgM antibody titer using the
Cat IgG and IgM ELISA Quantitation Kits (#E20-l 17 and E20-100), ELISA Starter
Accessory Package (#E101), and a quantitative ELISA immunoassay protocol, all
obtained from Bethyl Laboratories (Bethyl Laboratories, Inc., Montgomery, TX).
Reagents obtained from the Cat IgG and IgM ELISA Quantitation Kits and
ELISA Starter Accessory Package were allowed to warm to room temperature and all
steps were performed at room temperature. According to the provided protocol, the wells
of the 96-well microtiter plates were coated with capture antibody, either goat anti-cat
IgG-Fc affinity purified antibody for IgG detection or goat anti-cat IgM affinity purified
antibody for IgM detection. The affinity purified antibodies were diluted 1:100 in
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coating buffer and 1OOpl was added to the wells of the plate. The plate was incubated for
60 minutes then washed twice with wash solution.

Two hundred microliters of postcoat

solution was added to the wells and the plate was incubated for 30 minutes, then washed
twice with wash solution. Cat reference serum was diluted as per protocol in sample
diluent to serve as standards and previously collected serum samples from day 0, 7, 14,
and 21 were diluted in sample diluent at a range o f 1:4,000 to 1:10,000 (determined by
preliminary testing). One hundred microliters of standards and samples were added to
appropriate wells and incubated for 60 minutes, after which the plate was washed 4 times
with wash solution. The detection antibody/horseradish peroxidase (HRP) conjugate,
either goat anti-cat IgG-Fc HRP for IgG detection or goat anti-cat IgM HRP for IgM
detection, were diluted appropriately in sample diluent. One hundred microliters were
added to each well and incubated for 60 minutes, after which the plate was washed 4
times with wash solution. The enzyme substrate solution was prepared by mixing equal
volumes of TMB peroxidase substrate and peroxidase solution B (Kirkegaard and Perry
Laboratories, Gaithersburg, MD), and 100 pL of substrate was added to each well. Plates
were incubated 5-15 minutes (depending on intensity of color change), after which 100
pL of 2 M H2SO4 were added to each well. Plates were read at 450 nm on a Dynex MRX
plate reader and data was generated using Revelation software (Dynex Laboratories).
Flow Cytometric Analysis
Analysis of lymphocyte subsets on blood collected from old and young felines on
day 0, 30, and 60 of the treatment period was performed with single-color flow cytometry
by Dr. Boon Chew’s lab at Washington State University, Pullman, WA. Mouse
monoclonal antibodies (mAbs) to feline antigens used to quantitate the lymphocyte
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subsets were obtained from VMRD (Pullman, WA). Briefly, PBMCs were separated on
Histopaque-1119 (Sigma, St. Louis, MO) and contaminating red blood cells were lysed in
NH4CI (8.4 mg/ml) and cells were washed three times with phosphate buffered saline
(PBS, pH 7.4). Isolated PBMCs were resuspended to lxlO7 cells/ml in PBS
supplemented with 2% gamma globulin-free horse serum, 5% goat serum and 0.2mg/ml
sodium azide. A total of 5x105 cells were incubated for 30 minutes on ice with
monoclonal antibodies that recognize feline Total T cells (CD3+ cell, CF54A), CD4+
cells (CAT30A, helper T cells), and CD8+ cells (25-2A, cytotoxic T cells ). Cells were
then washed three times and secondary staining was performed by incubating cells with
fluorescein isothiocyanate (FITC)-conjugatetd goat F(ab’)2 anti-mouse immunoglobuin
(Ig) G (H+L) antibody (Cahag, Burlingame, CA) to visualize the bound mAb Stained
cells were fixed in 4% paraformaldehyde in preparation for acquisition and determination
by flow cytometry (FACScan, Becton Dickinson, San Jose, CA) after gating the
lymphocyte population by forward and side scatter analysis. For each sample, 5,000 total
events were acquired for analysis. Appropriate negative controls were included to correct
for background fluorescence. Data were expressed as the percentage of positive-staining
cells corrected for cells stained nonspecifically with the secondary antibody.
Statistics:
All statistical analyses were performed using the Statistical Analysis System
(SAS) statistical package version 8.0 (SAS Institute, Cary, NC). The General Linear
Model Procedure was used to analyze data with age, diet, and day as main effects. For
analysis o f the effects of Thiomax™ on lymphocyte subsets, values for young and old
felines from day 30 and 60 were grouped together. Significant differences were
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identified by the Least Squared Means test and Tukey’s honestly significant difference
(HSD) post hoc test. Significance was set at p < 0.05.
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RESULTS

Aging is associated with several physiological changes. An important
physiological change seen in aging is a shift in the balance between oxidants and
antioxidants, in which increased oxidants, or free radicals, lead to increased cellular
damage, also called oxidative stress. Antioxidants, both intracellular and exogenous,
counteract free radical damage to cells through the inactivation of these molecules. The
overall goal of this research was to determine whether or not supplementation with the
antioxidant cocktail Thiomax™ could reduce the damage caused by the age related
increase in oxidative stress and possibly restore function to levels comparable to those
seen in the young. In order to test this hypothesis, we choose several parameters in which
age related oxidative stress has a significant impact, using young and old felines. These
parameters include immune function, secretion of inflammatory mediators, lipid
peroxidation, and intracellular antioxidants. In order to assess the impact of age and
Thiomax™ supplementation on immune function we examined several immune
parameters. Lymphocyte function, dealing mainly with T lymphocytes, was assessed
using mitogen-induced lymphocyte proliferation as a measure of lymphocyte
responsiveness and flow cytometric analysis in order to determine T cells subsets and any
subsequent age related shifts. Humoral immunity was assessed by measuring IgM and
IgG antibody levels in response to vaccine challenge. Secretion of PGE2 was measured
in these animals since PGE2 is a molecule associated with inflammation and modulation
of cell-mediated immune responses. The innate intracellular antioxidant status in these
animals was measured through intracellular glutathione levels and the extent of cellular
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damage by oxidative stress was measured through lipid peroxidation levels in these
animals.
Effect o f Age on the Immune Function
In order to assess lymphocyte function, lymphocyte proliferation assays were
performed on isolated peripheral blood mononuclear cells (PBMCs) obtained from young
and aged felines. The T cell mitogens Con A and PHA, and the T and B cell mitogen
PWM were used to stimulate lymphocyte proliferation in vitro (data for PHA was not
significant). The optimal concentration for Con A and PWM was determined to be 2.5
pg/ml. Young felines had significantly greater lymphocyte proliferation than old felines
when stimulated with 2.5 pg/ml Con A (Figure 1A). Similarly, stimulation with 2.5
pg/ml PWM resulted in greater lymphocyte proliferation in young felines compared to
old felines, however this difference was not significant (p <0.10) (Figure IB).
Based on differences in proliferation, experiments were designed to determine
whether there were any changes in the distribution of T cell subsets. Flow cytometric
analysis was performed in order to measure T lymphocyte subsets in young and old
felines. When feline PBMCs from young and old felines were stained with CD3
antibody (total T cells), there was a significant decline (p<0.05) in total T cell population
in old felines compared to young (Figure 2A). Staining with CD4 antibody identified T
helper cells, and there was a strong trend towards a reduced (p=0.06) T helper cell
population in old cats (Figure 2B). Similarly, there was a significant decline (p<0.01) in
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Figure 1: The effect of age on mitogen-induced lymphocyte proliferation. Peripheral
blood mononuclear cells (PBMCs) from both young and old felines were stimulated with
2.5 (ig/ml Con A (1A) or 2.5 pg/ml PWM (IB). After 72 hours, 3H-thymidine
incorporation was assessed as a correlate of cellular proliferation. Values were expressed
as corrected counts per minute (cCPM). Different letters denote a statistically significant
difference between groups (p<0.05).
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Figure 2: The effect o f age in felines on T cell subsets using single color flow
cytometry. PBMCs from young and aged felines were labeled with monoclonal
antibodies (mAb) to CD3 (total T cells) (2A), CD4 (T-helper cells) (2B), and CD8
(cytotoxic T cells) (2C). Cells stained with the respective mAb were labeled with
fluorescein isothiocyanate (FITC)-conjugatetd goat F(ab’)2 anti-mouse IgG+IgM (H+L)d.
Labeled cells were run on a flow cytometer to obtain relative numbers o f the respective T
cell populations. Significance was determined by an R2 analysis and significance was set
at p<0.05.
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cytotoxic T cells stained with CD8 antibody in old felines compared to young felines
(Figure 2C).
Humoral immunity was assessed in young and old felines by measuring IgM and
IgG antibody levels in response to antigenic challenge with Fel-O-Vax® . Old felines
had significantly higher IgM antibody levels at days 0 and 7 post-challenge than young
felines, however there was no statistical difference at days 14 and 21 (Figure 3A). There
was no difference in IgG antibody levels between old and young felines on any day post
challenge (Figure 3B)
PGE2 is an important lipid inflammatory mediator intimately involved in immune
function, specifically impacting cell-mediated immunity. PBMCs from old and young
felines were stimulated with 2.5 pg Con A in order to measure the production of PGE2.
Younger cats produced significantly higher levels of PGE2 than old cats (Figure 4).
Influence o f Age on Intracellular Glutathione Levels and Lipid Peroxidation
The intracellular antioxidant glutathione was measured using erythrocyte lysates
obtained from old and young felines. Levels of intracellular glutathione in young felines
were significantly elevated compared to those in old felines (Figure 5A). Serum samples
from young and old felines were used to quantify lipid hydroperoxide production, which
correlates with oxidative stress and cellular damage. Compared to old felines, young
felines produced significantly higher amounts of lipid peroxides (Figure 5B).
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Figure 3: Effect o f age in antibody levels in young and aged felines. Young and old
felines were vaccinated with the Fel-O-Vax® vaccine, and 2 weeks later challenged with
the same vaccine. Serum was collected from all animals on days 0 ,7 14, and 21. Serum
was analyzed for IgM (3 A) and IgG (3B) levels using Cat IgG and IgM ELISA
Quantitation Kits. Values are expressed as ng/ml o f antibody. Different letters denote a
statistically significant difference between groups (p<0.05).
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Day

Figure 4: Prostaglandin Ej (PGEj) levels in young and aged fd tees. PBMCs from
old and young felines were stimulated with 2.5 pg Con A fix 18-20 hours. The
supernatants from each culture were collected and levels o f PGE2 were measured.
Different letters denote a statistically significant difference between groups (p<0.05).
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Figure 5: Effect o f age on intracellular glutathione levels and lipid peroxidation.
Intracellular glutathione from red blood cell lysates o f both young and old felines was
analyzed (5A). Serum samples from young and old felines were used to measure the
levels o f lipid peroxides, correlating to actual lipid peroxidation using a colorimetric
assay (5B). Values were expressed as pM amounts per sample. Different letters denote a
statistically significant difference between groups (p<0.05).
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Effect o f Thiomax™ supplementation on Selected Immune Parameters
In order to assess the impact of Thiomax™ supplementation on cell-mediated
immune function, lymphocyte proliferation assays were performed on isolated peripheral
blood mononuclear cells (PBMCs) from young and aged felines The mitogens Con A,
PHA, and PWM were used to stimulate lymphocyte proliferation in vitro. On day 30
young felines maintained on the control diet had significantly higher proliferation than
old feline PBMCs on the control diet when stimulated with 2.5 pg/ml Con A (Figure 6A).
On day 30, Thiomax™ supplementation increased proliferation of old feline PBMCs
stimulated with Con A to levels comparable with young feline values, however these
values were not significantly different from old controls (Figure6A). Thiomax™
supplementation had no effect on young felines at day 30 (Figure 6A). On day 60 of the
treatment period, there was no effect of Thiomax™ supplementation on either young or
old feline PBMCs stimulated with Con A (Figure 6A). When stimulated with 2.5 pg/ml
PWM on day 30, young feline PBMCs in either the control or Thiomax™ supplemented
group had significantly higher proliferation than old feline PMBCs on the control diet.
However, on day 30, Thiomax™ supplementation increased proliferation of old feline
PBMCs to levels compaiable with young control and Thiomax™ supplemented felines
when stimulated with PWM, however these values were not significantly different from
old controls (Figure 6B). There was no effect of Thiomax™ supplementation on days 0
and 60 for any treatment group stimulated with PWM (Figure 6B). In order to assess the
impact of Thiomax™ supplementation on T lymphocyte subsets in young and old felines,
low cytometric analysis was performed to measure T lymphocyte subsets. When total T
cells (CD3+), T helper cells (CD4+), and cytotoxic T
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Figure 6: Effect of Thiomax™ supplementation on mitogen-induced proliferation
in young and aged felines. PBMCs from young and old felines fed either a control or
Thiomax™ supplemented diet were stimulated with 2.5pg/ml Con A (6A) or 2.5 pg/ml
PWM (6B) on days 0, 30 , and 60 of the treatment period. After 72 hours, 3H-thymidine
incorporation was assessed as a correlate of cellular proliferation. Values were expressed
as corrected counts per minute (cCPM). Different letters denote a statistically significant
difference between groups (p<0.05), where as groups that share a letter are not
significantly different from each other.
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cells (CD8+) were measured there was no significant difference between young and old
felines on the Thiomax™ supplemented diet compared to young and old felines on the
control diet during the whole sampling period (Figure 7A-C).
The effect of Thiomax™ supplementation on humoral immunity was assessed in
young and old felines by measuring IgM and IgG antibody levels in response to antigenic
challenge with Fel-O-Vax® . On day 0 post challenge, old felines fed the Thiomax™
supplemented diet had significantly higher levels of IgM antibodies than the old control
group or the young felines, and on day 7, old felines supplemented with Thiomax™ had
significantly higher values that young felines in either group (Figure 8A). On day 21 post
challenge, old felines on either the control or Thiomax™ supplemented diet produced
significantly higher IgM levels compared to young felines (Figure 8A). There was no
effect of Thiomax™ supplementation on IgG antibody levels in any groups on any day
post challenge (Figure 8B).
PBMCs from old and young felines fed either control or Thiomax™
supplemented diet were stimulated with 2.5 pg Con A in order to measure the production
of PGE2. On day 0 young felines exhibited elevated levels of PGE2 compared to old
felines (Figure 9). However, animals maintained on Thiomax™ exhibited no difference
when compared to controls (Figure 9). On day 60 Thiomax™ supplementation
significantly increased PGE2 production in old feline PBMCs compared to those on the
control diet, but supplementation did not affect PGE2 levels in young animals (Figure 9).
No effect was seen at day 30 (Figure 9).
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Figure 7: Impact of Thiomax™ supplementation T cell subsets in young and aged
felines using single color flow cytometry. PBMCs from young and old felines on either
the control or Thiomax™ supplemented diet were labeled with monoclonal antibodies
(mAb) to CD3 (total T cells) (7A), CD4 (T-helper cells) (7B), and CD8 (cytotoxic T
cells) (7C). Cells stained with the respective mAb were labeled with fluorescein
isothiocyanate (FITC)-conjugatetd goat F(ab’)2 anti-mouse IgG+IgM (H+L)d Labeled
cells were run on a flow cytometer to obtain relative numbers of the respective T cell
populations. Values for young and old felines from day 30 and 60 were grouped together
for analysis. Different letters denote a statistically significant difference between groups
(p<0.05).
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Figure 8: Effect of Thiomax™ supplementation on IgM and IgG levels in young
and aged felines. Young and old felines on either a control or Thiomax™ supplemented
diet were vaccinated with the Fel-O-Vax® vaccine, and 2 weeks later challenged with the
same vaccine. Serum was collected from all animals on days 0, 7 14, and 21. Serum was
analyzed for IgM (8A) and IgG (8B) levels. Values are expressed as ng/ml of antibody.
Different letters denote a statistically significant difference between groups (p<0.05),
where as groups that share a letter are not significantly different from each other.
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Figure 9: Influence of Thiomax™ supplementation on prostaglandin E2 (PGE2)
production in young and aged felines. PBMCs from old and young felines were
stimulated with 2.5 pg Con A for 18-20 hours. The supernatants from each culture were
collected and levels of PGE2 were measured. Different letters denote a statistically
significant difference between groups (p<0.05), where as groups that share a letter are not
significantly different from each other.
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D ay

Influence o f Thiomax™ supplementation on Intracellular Glutathione Levels and Lipid
Peroxidation
On day 30 of the treatment period, Thiomax™ supplementation resulted in an
increase in glutathione production in young felines, however, in aged animals there was a
reduction in glutathione (Figure 10A). However, these values were not statistically
different (Figure 10A). There was no significant difference in intracellular glutathione
levels between groups on day 0 and 60 (Figure 10A). In order to assess oxidative stress,
serum samples from young and old felines were used to measure lipid hydroperoxide
production. On day 0 of the treatment period, young felines fed a Thiomax™
supplemented diet, had significantly elevated levels of lipid hydroperoxide when
compared with young control and old felines (Figure 10B). On day 30, young felines on
either the control or Thiomax™ supplemented diet had higher serum levels of lipid
hydroperoxides than old felines, however old felines on the Thiomax™ supplemented
diet had slightly elevated levels compared to old control and similar to young felines
(Figure 10B).
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Figure 10: Impact of Thiomax™ supplementation on intracellular glutathione
levels and Upid peroxidation in young and aged felines. Intracellular glutathione from
red blood cell lysates of both young and old felines from days 0, 30, and 60 of the
treatment period were analyzed (10A). Serum samples from young and old felines on
days 0, 30, and 60 of the treatment period were used to measure the levels of lipid
peroxides (10B). Values were expressed as tiM amounts per sample. Different letters
denote a statistically significant difference between groups (p<0.05), where as groups that
share a letter are not significantly different from each other.
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DISCUSSION

The objective of this study was to determine whether age and/or diet had any
effect on immune function, through measurement of mitogen-induced lymphocyte
proliferation, lymphocyte subsets, antibody production, and PGE2 production in young
and old felines. Similarly, the effects of Thiomax™ on glutathione status, and oxidative
stress, as measured by serum lipid peroxidation, were measured in these animals.
In order to assess the effect of age on cell-mediated immune function and
lymphocyte responsiveness, mitogen-induced lymphocyte proliferation was assayed in
PBMCs obtained from young and old felines. Data from these experiments demonstrate
that following stimulation with 0.25pg of ConA, old feline PBMCs had significantly
lower lymphocyte proliferation than PBMCs from young felines (Figure 1A).
Stimulation with 0.25pg PWM produced a similar trend of reduced lymphocyte
proliferation in old feline PBMCs compared to young feline PBMCs, though not
significant (Figure IB). These findings are consistent with a study in which old felines
had significantly reduced mitogen-induced lymphocyte proliferation in response to Con
A and PHA compared to young felines (83). In a study by Meydani et al., young canine
PBMCs stimulated with the mitogens Con A and PHA had significantly higher
proliferation than old canine PBMCs stimulated with the same mitogens (82). In a
similar study, mitogen-induced proliferation in response to Con A, PHA, and PWM was
significantly lower in old canines compared to young canines (81). This reduced
proliferative response to mitogen stimulation is also seen in humans, highlighted by a
study in which PBMCs from elderly subjects had significantly reduced lymphocyte
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proliferation in response to PHA (34). This trend of reduced proliferative response to
mitogenic stimulation in the aged is also seen in the murine model (27, 31, 33).
Another parameter used to assess the impact of age on immune function was the
enumeration of lymphocyte subsets. In order to delineate relative numbers of T
lymphocyte subsets in old and young felines, flow cytometric analysis was performed on
young and old feline PBMCs stained with antibodies for specific T lymphocyte antigens,
including CD3 (total T cells), CD4 (helper T cells), CD8 (cytotoxic T cells). We found
that there was a significant decrease in CD3+ and CD8+T cells, as well as a strong trend
towards a decrease in CD4+ T cells in old felines compared to young felines (Figure 2AC). In companion animals, there seems to be some discrepancy as to the aged related
alterations in these T cell subsets. Kearns et al. reported decreased percentages of total T
cells and CD4 cells, but not CD8+ cells, in old canines compared to young canines (80).
Another study found similar levels of CD3+ T cells and CD8+ T cells in young and old
canines, but a decrease in CD4+ cells in old canines compared to young canines (91).
Conversely, Greeley et al. reported decreased total T cells in young canines compared to
old canines, whereas CD4' and CD8+ values were similar between age groups (81).
While there are discrepancies in the data, there seems to be a common trend of decreased
CD4+ T cells, which agrees with our findings of a strong trend towards decreased CD4+
cells in aged felines. However, in our study we also found significant decreases in CD3+
and CD8+ T cells, conflicting with some of the previous studies done in the canine model
system.
A decrease of the CD4+ compartment of T cells may have a significant impact on
immune function. CD4+Helper T cells (Th cells) produce IL-2, which is essential for T
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cell growth. In humans(35) and mice (27), aged subjects produce significantly less IL-2
than young subjects. This reduction of IL-2 production seen in the aged may be a
consequence of decreased CD4+ T cell subsets. The decrease in IL-2 may contribute to a
decrease in CD8+ T cells, and this decrease may impact the ability of an individual to
fight infections and cancer.

CD4+Th cells also secrete cytokines such as IL-4, which

play an integral role in humoral immunity through activation and differentiation of B
cells (42). Therefore a decrease in CD4+ T cells could negatively impact both cellmediated and humoral immune function. CD4+Th cells also aid in the activation of
macrophages by production of interferon-y (IFN-y). Activated macrophages act as potent
antigen presenting cells as well as facilitating the clearance of bacterial pathogens
through phagocytic and cytotoxic mechanisms. There is a dearth of information
concerning aged related changes in lymphocyte subsets in companion animals, especially
in the feline model, and further studies need to be conducted to find consistent results.
Humoral immunity was assessed in young and old felines by measuring IgM and
IgG antibody levels in response to antigenic challenge with Fel-O-Vax®. Old felines had
significantly higher IgM antibody levels at days 0 and 7 than young felines (Figure 3A),
demonstrating an age difference in B cell responses and IgM production. IgM is the first
antibody secreted in a primary immune response, whereas upon secondary challenge IgG
is the primary antibody produced. This elevated IgM production seen in aged felines
post-challenge may be due to an inadequate or depressed memory B cell response. In a
study by Brietbart et al., elderly human subjects had significantly lower percentages of
memory B cells(32). Although percentages of memory B cells were not measured in this
study, alterations in the memory B cell compartment may have led to the elevated IgM
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production seen in these aged felines. CD4+Th cells secrete cytokines which influence
the class of antibody produced during an immune response (24), and a change in the
CD4+Th cell compartment in aged individuals may impact antibody production.
However, it seems in felines that the production of IgG in response to antigenic challenge
is not influenced by age. In this study, however, only total IgG and IgM antibody
production were measured, and antigen specific antibody responses were not assessed. In
a study by Gardner et al., elderly subjects had significantly decreased antibody titers to
three different influenza vaccines compared to young subjects (36). Measurement of
antigen specific antibody responses in future studies may elucidate potential differences
in humoral immune function in young and aged felines.
PGE2 is an important lipid inflammatory mediator with numerous and diverse
biological functions. PGE2 is involved in bronchodilation, modulation of inflammatory
responses, and wound repair(92). PGE2 is intimately involved in immune function,
impacting cell-mediated immune responses as well as the production of cytokines(93). In
T cells PGE2 can inhibit proliferation and IL-2 production, regulate T cell maturation and
activation, and induce CD4 Th cells to secrete Tr2 cytokines, such as IL-4 and IL-10
(93, 94). In this study, younger cats produced significantly higher levels of PGE2 than
old cats (Figure 4). Based on several murine macrophage experiments in which aged
murine macrophages produced significantly higher levels of PGE2than young murine
macrophages (47-49), the expected result would be an increased production in aged
felines and not in young felines. The feline model system is one that has not been studied
as exhaustively as the rodent or human system, and felines may respond differently in
their secretion and response to PGE2 The elevated levels of PGE2 produced by young
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felines did not negatively impact mitogen-induced lymphocyte proliferation. Therefore,
the young felines may not be as sensitive to PGE2 as old felines.
Glutathione (GSH) is an important intracellular antioxidant with potent free
radical scavenging capabilities. Levels of intracellular GSH in young felines were
significantly elevated compared to those in old felines (Figure 5A). Studies have
confirmed the age related decrease in intracellular glutathione in aged humans (95), and
rodents (10, 51, 75) In the murine model, this decrease in glutathione in the aged is
accompanied by decreased in vivo (delayed-type hypersensitivity (DTH)) and in vitro
(mitogen-induced lymphocyte proliferation) cell-mediated immune responses (75). In in
vitro studies in which intracellular GSH has been depleted, there is a marked decrease in
lymphocyte proliferation in human PBMCs (54). In an in vitro study using human skin
fibroblast and human umbilical vein endothelial cells, depleting cells of intracellular GSH
significantly increased mitogen-stimulated PGE2 production(55). Reduced glutathione
levels in the aged may contributed to reduced immune function through reduced
lymphocyte activation and proliferation as well as increasing the secretion of PGE2,
which at high levels exerts an immunosuppressive effect. In our study, old felines
showed significantly reduced mitogen-induced lymphocyte proliferation to Con A than
young felines, which may be due in part to significantly reduced levels of intracellular
glutathione in old felines.
Lipid peroxidation can occur as a consequence of free radical attack, or oxidative
stress, on lipids of the cell membrane resulting in disruption of membrane integrity and
fluidity. In this study, serum samples from young and old felines were used to quantify
lipid hydroperoxide production, which correlates to oxidative stress and cellular damage.
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Compared to old felines, young felines produced significantly higher amounts of lipid
peroxides (Figure 5B). Aging is associated with increased lipid peroxidation (6) and
studies with rat hepatocytes showed significantly increased levels of lipid
hydroperoxides, a by product of lipid peroxidation, in aged rat hepatocyte plasma
membranes than those in young rats. However, in our study we found significantly
higher lipid peroxidation in young verses old felines. This may be due to several factors.
Collecting blood by veinipuncture in felines is a very stressful and invasive event for
these animals, compared to canines or humans. At the time of blood collection these
animals are undergoing extreme stress, especially the younger felines who may not be
conditioned for this procedure. Serum samples are a snap shot in time for these animals,
reflecting their condition right at the time of collection, not necessarily their overall
condition. Therefore these younger felines might have been experiencing a load of stress
(increased respiration and production of free radicals) greater than the older felines,
reflected in higher lipid peroxidation values, translating into oxidative stress. Although
the young felines had higher levels of lipid peroxides than old felines, they may be able
to cope better with oxidative stress. It has been shown in rodents that several exogenous
antioxidant enzymes decrease with age including superoxide dismutase, catalase, and
glutathione peroxidase, as well as the aforementioned glutathione (51). It may be that
younger felines are better equipped to deal with oxidative stress since their endogenous
antioxidant defense system is more robust than those in old felines. PGE2 was
significantly elevated in young felines compared to old felines, and this may be a
consequence of increased lipid peroxidation seen in young felines. Since prostaglandin
production is initiated by peroxidation of membrane polyunsaturated fats (5), the
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increased lipid peroxidation seen in young felines may contribute to the significantly
higher levels of PGE2 compared to old felines.
As well as discerning age related changes in several parameters looked at in this
study, we also assessed the impact of Thiomax™ supplementation on immune function.
Thiomax™, manufactured by Health Span Sciences, is a proprietary antioxidant cocktail
composed of a-lipoic acid and n-propyl gallate. a-Lipoic acid has a naturally occurring
form, the R-enantiomer, and a synthetic form composed of a 1:1 mixture of the R- and Senantiomers, which is used as nutritional supplements (88). a-Lipoic acid is taken into
the cell and rapidly converted to its reduced form, dihydrolipoic acid (DHLA), which is a
more potent antioxidant than a-lipoic acid (89). a-Lipoic acid and its reduced form
DHLA have potent free radical scavenging properties against several reactive oxygen
intermediates (60). In a study by Jones et al., pre-incubation of an endothelial cell line
with a-lipoic acid neutralized H2O2 in culture produced by menadione, which is a known
H2O2 generator (89). Since mitochondria produce H2O2 as a consequence of respiration,
a-lipoic acid could therefore help to reduce the amount of oxidative stress in the cell
(89). a-Lipoic acid also participates in important redox interactions with other
endogenous antioxidants (88). The a-lipoic acid/DHLA redox couple seem to be able to
regenerate several important endogenous antioxidants including ascorbate (vitamin C)
and vitamin E, supported by evidence that a-lipoic acid supplementation prevented
symptoms of vitamin C and E deficiencies (60). Another important interaction of alipoic acid is that a-lipoic acid supplementation increases intracellular glutathione
concentrations both in vivo and in vitro (88, 89). In a study by Huhberg et al., the
addition of 100 and 500 pM a-lipoic acid to HeLa cells for 3 days significantly increased
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intracellular glutathione concentration compared to the controls (96). Cysteine is
essential for glutathione synthesis, but when cysteine is extracellular it can be rapidly
oxidized to cystine, thereby limiting glutathione synthesis (96). a-Lipoic acid is taken up
into the cell and rapidly reduced to dihydrolipoic acid (DHLA), which is released out of
the cell and reduces extracellular cystine to cysteine, thereby allowing cysteine uptake
and glutathione synthesis (96). It is because of a-lipoic acid’s many antioxidant
properties that it is dubbed “a universal antioxidant”.
n-Propyl gallate is a synthetic antioxidant used extensively in fats and oils to
prevent spoilage, as a food preservative to prevent lipid peroxidation, and in cosmetics.
n-Propyl gallate is a chain breaking antioxidant, which stops lipid peroxidation through
prevention of propagation of further radicals and can function to inactivate reactive
oxygen intermediates before they can initiate the lipid peroxidation process (97). nPropyl gallate also exerts a protective effect by enhancing the antioxidant enzymes
catalase, which reduces H2O2 to water and oxygen, and glutathione reductase, which
regenerates reduced glutathione (GSH)(98). n-Propyl gallate has been shown to protect
glutathione depleted lens epithelial cells from oxidative injury when exposed to H2O2
(90). In another study, mice supplemented with n-propyl gallate were exposed to
phosgene, which caused lung injury, and supplementation with n-propyl gallate increased
survival, reduced lipid peroxidation, and prevented phosgene-induced glutathione
depletion in the lungs compared to control mice (98). The components of Thiomax™
have potent antioxidant properties and it was our aim to assess if dietary supplementation
with this antioxidant cocktail would affect immune function in young and aged animals.
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The effect of Thiomax™ on mitogen-induced lymphocyte proliferation was
measured using PBMCs from young and old felines. Thiomax™ supplementation
increased proliferation of PBMCs from old felines stimulated with 0.25 pg of Con A or
PWM on Day 30 (Figure 6A-B). This increase in proliferation suggests there maybe a
beneficial effect of Thiomax™ supplementation in old felines, however the same may not
hold true for young felines since Thiomax™ had no effect on proliferation in young
•
TM
felines. While there was a possible trend of increased proliferation with Thiomax
supplementation, there was no effect of Thiomax™ supplementation on lymphocyte
subsets in old or young felines.
In contrast to our results, several studies have confirmed that antioxidant
supplementation increased mitogen-induced lymphocyte proliferation and modulated
lymphocyte subsets in companion animals. P-carotene supplementation has been shown
to increase mitogen-induced proliferation of PBMCs in response to Con A, PHA, and
PWM in both young and old canines, and also increased the percentage of CD3+ and
CD4 T cells in old canines compared to old canines on a control diet (80). In another
study, P-carotene supplementation of 20 or 50 mg/day significantly increased the
percentage of CD4' T cells on week 8 of treatment (84).

Similarly, dietary lutein

supplementation in young canines and felines significantly increased mitogen-induced
lymphocyte proliferation (86, 87). In canines, 20 mg/day of dietary lutein increases the
percentage of total T cells and CD8+ T cells at 8 weeks of treatment, whereas 5 mg/day of
dietary lutein increased the percentage of total T cells and CD4+ T cells at 12 weeks of
supplementation (87). In felines, 10 mg/day of dietary lutein significantly increased
CD4+ T cells at 12 weeks of supplementation (86). In old felines, vitamin E
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supplementation significantly increased mitogen-induced proliferation in response to Con
A stimulation compared to old felines on a control diet (83).
The effect of Thiomax™ supplementation on humoral immunity was assessed by
measuring IgM and IgG antibody levels in response to antigenic challenge with Fel-OVax® . On day 0 and 7 post-challenge, old felines on the Thiomax™ supplemented diet
had significantly higher IgM levels than young felines while on day 21 old felines had
higher IgM levels than young cats regardless of treatment group (Figure 8A). In either
young or old felines, Thiomax™ supplementation did not increase IgM or IgG
production compared to the age matched controls (Figure 8A-B). There was no
significant difference between groups, either old or young, control or Thiomax™
supplemented, in IgG levels in reponse to vaccine challenge (Figure 8B).
Several studies have shown that antioxidant supplementation can increase
antibody production in companion animals in response to antigenic challenge. Increased
antibody production would be beneficial since antibodies serve an important protective
function against bacterial and viral infections in which they serve to neutralize infectious
particles and toxins and aid in the recruitment of immune cells and clearance of
microorganisms. In canines, dietary lutein increased IgG production (87) and J3-carotene
supplementation increased IgG and IgM production (84, 85) in response to antigenic
challenge. Similarly, dietary lutein increased IgG production in felines (86).
In evaluating the effects of Thiomax™ on PGE2 levels, we demonstrated that
Thiomax™ supplementation did not have an effect on PGE2 in young or old felines. In
fact, Thiomax™ supplementation significantly increased PGE2 production in old felines
compared to old felines on the control diet on day 60 (Figure 9). As stated before, aged
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animals have higher PGE2 production than younger animals, which can be
immunosuppressive. Several studies have shown that supplementation with antioxidants,
especially vitamin E, has an suppressive effect on inappropriate secretion of PGE2. With
murine macrophages, supplementation with the antioxidants vitamin E and melatonin
significantly reduced the spontaneous release of PGE2 compared to control animals (4),
while in another study vitamin E supplementation significantly reduced the amount of
PGE2 produced by old murine macrophages when stimulated with LPS (48).
As noted, several studies have documented the immunomodulatory effect of
antioxidants on companion animals. In our study, we did not see a significant effect of
Thiomax™ supplementation on mitogen-induced lymphocyte proliferation, lymphocyte
subsets, antibody production, or PGE2 production. There seems to be a trend towards
increased proliferation in old felines, but not young felines, on the Thiomax™
supplemented diet, but only on day 30. The sample size for our experiments were 10
felines per treatment group, so perhaps a larger sample size may be needed to determine
the significance of Thiomax™ supplementation on these selected immune parameters.
At the conclusion of the study, it was also determined that the dose of Thiomax™, backcalculated from human experiments, was 3 times higher than it should have been. This
overestimation of the dose of Thiomax™ may have contributed to suppression or lack of
response since the optimal dose may not have been achieved. Further testing with the
correctly calculated concentration and increased numbers in treatment groups may yield
more consistent results. In addition, a-lipoic acid, a component of Thiomax™, has been
shown to have some prooxidant properties (88). Since the dose of Thiomax™ was higher
than was optimal for humans, Thiomax™ may have exerted a prooxidant effect, creating
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an environment of oxidative stress, thereby not having the antioxidant effect Thiomax

TM

was purported to have.
As stated previously, a-lipoic acid, a component of Thiomax™, has been shown
to increase intracellular glutathione levels. There was no effect of Thiomax
supplementation on young or old cats in this study, Thiomax™ did not increase
intracellular glutathione (Figure 10A). In addition, Thiomax™ did not reduce lipid
peroxidation in the serum of young or old felines. Ironically, felines maintained on the
Thiomax™ supplemented diet had higher lipid peroxidation than old felines on the
control diet (Figure 10B). Again, the overestimation of the dose of Thiomax™ may have
contributed to the lack of effect seen in these felines in regards to glutathione and lipid
peroxidation.
In summary, this study confirmed the age related decrease in mitogen-induced
lymphocyte proliferation, lymphocyte subsets, and intracellular glutathione. Age related
changes in PGE2 production and lipid peroxidation were atypical of results in other
animal models, therefore more testing needs to be done to determine normal levels of
PGE2 and lipid peroxidation in old and young felines. We were not able to find any
effect of Thiomax™ supplementation in young and old felines in any of the parameters
measured. Subsequent studies need to be conducted in which the optimal Thiomax™
concentration is used with increased sample sizes.
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